These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16299326)

  • 1. Protective immunity to the larval stages of onchocerca volvulus is dependent on Toll-like receptor 4.
    Kerepesi LA; Leon O; Lustigman S; Abraham D
    Infect Immun; 2005 Dec; 73(12):8291-7. PubMed ID: 16299326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of Onchocerca volvulus keratitis (river blindness): a novel role for TLR4 and endosymbiotic Wolbachia bacteria.
    Hise AG; Gillette-Ferguson I; Pearlman E
    J Endotoxin Res; 2003; 9(6):390-4. PubMed ID: 14733727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
    Hise AG; Daehnel K; Gillette-Ferguson I; Cho E; McGarry HF; Taylor MJ; Golenbock DT; Fitzgerald KA; Kazura JW; Pearlman E
    J Immunol; 2007 Jan; 178(2):1068-76. PubMed ID: 17202370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.
    MacDonald AJ; Tawe W; Leon O; Cao L; Liu J; Oksov Y; Abraham D; Lustigman S
    Parasite Immunol; 2004 Jan; 26(1):53-62. PubMed ID: 15198646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 (TLR4) is required for protective immunity to larval Strongyloides stercoralis in mice.
    Kerepesi LA; Hess JA; Leon O; Nolan TJ; Schad GA; Abraham D
    Microbes Infect; 2007 Jan; 9(1):28-34. PubMed ID: 17196865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4.
    Brattig NW; Bazzocchi C; Kirschning CJ; Reiling N; Büttner DW; Ceciliani F; Geisinger F; Hochrein H; Ernst M; Wagner H; Bandi C; Hoerauf A
    J Immunol; 2004 Jul; 173(1):437-45. PubMed ID: 15210803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against Onchocerca volvulus and O. lienalis infective larvae in mice.
    Taylor MJ; van Es RP; Shay K; Folkard SG; Townson S; Bianco AE
    Trop Med Parasitol; 1994 Mar; 45(1):17-23. PubMed ID: 8066376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice.
    Lange AM; Yutanawiboonchai W; Scott P; Abraham D
    J Immunol; 1994 Jul; 153(1):205-11. PubMed ID: 8207236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of Onchocerca volvulus keratitis (river blindness): a novel role for endosymbiotic Wolbachia bacteria.
    Pearlman E
    Med Microbiol Immunol; 2003 Feb; 192(1):57-60. PubMed ID: 12592565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filaria/Wolbachia activation of dendritic cells and development of Th1-associated responses is dependent on Toll-like receptor 2 in a mouse model of ocular onchocerciasis (river blindness).
    Daehnel K; Gillette-Ferguson I; Hise AG; Diaconu E; Harling MJ; Heinzel FP; Pearlman E
    Parasite Immunol; 2007 Sep; 29(9):455-65. PubMed ID: 17727569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae.
    Abraham D; Leon O; Schnyder-Candrian S; Wang CC; Galioto AM; Kerepesi LA; Lee JJ; Lustigman S
    Infect Immun; 2004 Feb; 72(2):810-7. PubMed ID: 14742524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.
    MacDonald AJ; Turaga PS; Harmon-Brown C; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2002 Jun; 70(6):2796-804. PubMed ID: 12010965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions.
    Lustigman S; MacDonald AJ; Abraham D
    Int J Parasitol; 2003 Sep; 33(11):1161-71. PubMed ID: 13678632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
    George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.
    Turaga PS; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2000 Apr; 68(4):1905-11. PubMed ID: 10722581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to third stage larvae of Onchocerca volvulus in interferon-gamma and interleukin-4 knockout mice.
    Johnson EH; Schynder-Candrian S; Rajan TV; Nelson FK; Lustigman S; Abraham D
    Parasite Immunol; 1998 Jul; 20(7):319-24. PubMed ID: 9717193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective immunity against larval Onchocerca volvulus in a mouse model.
    Lange AM; Yutanawiboonchai W; Lok JB; Trpis M; Abraham D
    Am J Trop Med Hyg; 1993 Dec; 49(6):783-8. PubMed ID: 8279644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
    Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
    Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.